Carton label: Mycophenolate Mofetil for injection
Failed Dissolution Specifications
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Failed Dissolution Specifications
Cause type: Dissolution failure
The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.
Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.
Compare with the code on your package — it is the most precise check available.
From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.
| Product | Strength | Form & route | Labeler | Type |
|---|---|---|---|---|
| Acamprosate Calcium acamprosate calcium enteric-coated NDC 00378-6333 |
ACAMPROSATE CALCIUM 333 mg/1 | Tablet, Delayed Release Oral |
Mylan Pharmaceuticals Inc. | Rx |
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.
Failed Dissolution Specifications
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
Presence of precipitate
Failed Dissolution Specifications
Failed Dissolution Specifications
Failed dissolution specifications.
Failed Dissolution Specifications
Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.